HOMEwww.epgonline.orgDRUGSwww.epgonline.orgDISEASE KNOWLEDGEwww.epgonline.orgGUIDELINESwww.epgonline.orgCLINICAL TRIALSwww.epgonline.orgREGISTERwww.epgonline.orgSEARCH
Members
Why a doctor should
Username/Email

Password ()




EPG on Twitter EPG Online Twitter
EPG Online Blog EPG Online Blog
EPG Online Disease Knowledge Centres Feed Disease Knowledge
Recent UK Drug Updates Drug Updates
EPG Search
Search
Languages

JECTOFER overview
For the treatment of iron- deficiency anaemia and the rapid replacement of iron stores.
banner_pass = 1

Please register to access disease diagnosis, patient management, physician tools.
By viewing the content of this web page you are both confirming your status as a healthcare professional and agreeing to our terms of use.

Change language Current language database: English
 
 
Related DrugsDrug Details
JECTOFER
Drug Class Description :

Haematinics (iron supplements).

Generic Name :

Iron-sorbitol

Drug description :

Dark brown liquid for injection in ampoules.

Presentation :

Injection, iron-sorbitol (equivalent to 50mg Fe per mL).

Indications :

For the treatment of iron- deficiency anaemia and the rapid replacement of iron stores.

Adult Dosage :

1.5 mg/kg intramuscularly as single daily dose; maximum 100 mg per injection per day. Number of doses determined by haemoglobin level; see Summary of Product Characteristics. Discontinue oral iron 24 hours before use.

Child Dosage :

Under 3 kg (7lb), not recommended; over 3 kg, same as adult.

Elderly Dosage :

By intramuscular injection on alternate days.

Contra Indications :

Acute renal disorders, hepatic insufficiency. Ineffective in aplastic or hypoplastic anaemias and acute leukaemia. Untreated UTI, early pregnancy. Known UTI, early pregnancy. Known hypersensitivity to iron or Jectofer. Intravenous use.

Special Precautions :

Asthma, history of allergies, iron storage diseases, haemoglobinopathies. Elderly, underweight or debilitated patients. Should not be used to treat anaemias other than iron- deficiency anaemia.

Interactions :

Chloramphenicol.

Adverse Reactions :

Injection site reactions, transient metallic taste or loss of taste, headache, GI upset, dizziness, flushing, haematuria, myalgia, urticaria, hypotension, increased sweating, circulatory collapse, cardiac arrhythmias, palpitations, pressure sensations in chest. Very rarely, anaphylaxis.

Manufacturer :

AstraZeneca

Drug Availability :

(POM)

Drug Updated :

27 March 2009

Related Drugs - Anaemia & neutropenia
Soft Tissue Sarcoma Male hypogonadism is the term used to describe decreased functional activity of the testes with diminished production and action of testosterone. The prognosis of patients with diabetes is improved by interventions that reduce HbA1C Niemann-Pick Type C
New and updated Drugs
UK Drugs EPG Medical News Feed
Spanish Drugs EPG Medical News Feed
German Drugs EPG Medical News Feed
Norweigan Drugs EPG Medical News Feed
Netherlands Drugs EPG Medical News Feed
Swedish Drugs EPG Medical News Feed
French Drugs EPG French Drugs Feed
Portuguese Drugs EPG Portuguese Drugs Feed
Italian Drugs EPG Italian Drugs Feed

Atopic Dermatitis

Atopic Dermatitis

CONNECT

DISEASE CENTRES Disease Centres feed

AFFILIATE PARTNERS

QUICK SEARCH

GUIDELINES UK Drug Data Feed

DRUG DATA UK Drug Data Feed

REFERENCES